EPCAM and head and neck squamous cell carcinoma: Alternatively to Hsu and colleagues, we describe a novel functional cross talk of EGFR and EpCAM that regulates proliferation and EMT (Fig 9), which provides a molecular basis for differences in clinical outcome of subgroups of HNSCC patients.